Related Experiment Video
Updated: May 2, 2026
10:52
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
Published on: March 30, 2018
10.6K
A jagged road to lymphoma aggressiveness
Vedran Radojcic1, Ivan Maillard2
1Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109, USA; Division of Hematology-Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
Cancer Cell
|March 22, 2014
Summary
Researchers found that FGF4/Jagged1 signaling between lymphoma cells and blood vessels activates Notch signaling. This pathway fuels cancer aggressiveness, revealing new therapeutic targets for B cell lymphomas.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- B cell lymphomas are aggressive cancers.
- Tumor microenvironments play a crucial role in cancer progression.
- Angiocrine functions, signaling from blood vessels, are implicated in cancer.
Purpose of the Study:
- To investigate the crosstalk between tumor cells and the vascular niche in B cell lymphomas.
- To identify the molecular mechanisms sustaining lymphoma aggressiveness.
- To explore novel therapeutic strategies targeting tumor-vasculature interactions.
Main Methods:
- Utilized mouse and human B cell lymphoma models.
- Investigated the role of FGF4 and Jagged1 signaling.
- Analyzed Notch pathway activation in tumor and vascular cells.
- Assessed the impact of identified pathways on cancer aggressiveness.
Main Results:
- Identified a specific crosstalk driven by FGF4/Jagged1 between lymphoma cells and their vascular niche.
- Demonstrated that this crosstalk activates Notch signaling.
- Showed that activated Notch signaling sustains the aggressiveness of B cell lymphomas.
- Confirmed these findings in both mouse and human lymphoma models.
Conclusions:
- FGF4/Jagged1-driven tumor-vascular crosstalk is a key driver of B cell lymphoma aggressiveness.
- Targeting this pathway, particularly Notch signaling and angiocrine functions, offers new therapeutic opportunities.
- This research opens avenues for developing novel anti-cancer therapies for lymphomas.
Related Concept Videos
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
02:07Tumor Progression
3.1K
3.1K
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
02:53Adaptive Mechanisms in Cancer Cells
3.8K
3.8K
02:56Treatment Resistant Cancers
2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
02:18Cancer
51.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.7K